SG11202103289SA - Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof - Google Patents

Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof

Info

Publication number
SG11202103289SA
SG11202103289SA SG11202103289SA SG11202103289SA SG11202103289SA SG 11202103289S A SG11202103289S A SG 11202103289SA SG 11202103289S A SG11202103289S A SG 11202103289SA SG 11202103289S A SG11202103289S A SG 11202103289SA SG 11202103289S A SG11202103289S A SG 11202103289SA
Authority
SG
Singapore
Prior art keywords
coelenterazine
analogs
stabilizing
derivatives
compositions
Prior art date
Application number
SG11202103289SA
Other languages
English (en)
Inventor
Melanie Dart
Thomas Smith
Thomas Kirkland
Thomas Machleidt
Keith Wood
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of SG11202103289SA publication Critical patent/SG11202103289SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0018—Pullulan, i.e. (alpha-1,4)(alpha-1,6)-D-glucan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/34—Heterocyclic compounds having nitrogen in the ring
    • C08K5/3442—Heterocyclic compounds having nitrogen in the ring having two nitrogen atoms in the ring
    • C08K5/3462—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L25/00—Compositions of, homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Compositions of derivatives of such polymers
    • C08L25/02—Homopolymers or copolymers of hydrocarbons
    • C08L25/04—Homopolymers or copolymers of styrene
    • C08L25/06—Polystyrene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202103289SA 2018-10-03 2019-10-03 Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof SG11202103289SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862740622P 2018-10-03 2018-10-03
US201962805517P 2019-02-14 2019-02-14
PCT/US2019/054501 WO2020072775A2 (en) 2018-10-03 2019-10-03 Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof

Publications (1)

Publication Number Publication Date
SG11202103289SA true SG11202103289SA (en) 2021-04-29

Family

ID=68296818

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103289SA SG11202103289SA (en) 2018-10-03 2019-10-03 Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof

Country Status (11)

Country Link
US (2) US11534504B2 (ja)
EP (2) EP4015644A1 (ja)
JP (1) JP7447101B2 (ja)
KR (1) KR20210072040A (ja)
CN (1) CN112996923A (ja)
AU (1) AU2019355136A1 (ja)
BR (1) BR112021006298A2 (ja)
CA (1) CA3114424A1 (ja)
IL (1) IL281844A (ja)
SG (1) SG11202103289SA (ja)
WO (1) WO2020072775A2 (ja)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11201903A (ja) * 1998-01-19 1999-07-30 Doujin Kagaku Kenkyusho:Kk カルシウムイオン分析法およびそれに用いる試薬
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
US7659078B1 (en) * 2002-07-17 2010-02-09 University Of Kentucky Research Foundation Method and kit for determination of prostacyclin in plasma
EP3312292B1 (en) 2005-05-31 2019-09-25 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US20080248511A1 (en) 2007-03-26 2008-10-09 Promega Corporation Methods to quench light from optical reactions
GB0905410D0 (en) 2009-03-28 2009-05-13 Gentronix Ltd Genotoxicity testing
KR101665352B1 (ko) 2009-05-01 2016-10-12 프로메가 코포레이션 광 출력이 향상된 합성 오플로포러스 루시퍼라제
US8847872B2 (en) 2010-07-07 2014-09-30 Himax Display, Inc. Display for driving a pixel circuitry with positive and negative polarities during a frame period and pixel circuitry
EP3498709A1 (en) 2010-11-02 2019-06-19 Promega Corporation Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use
CN103180324A (zh) 2010-11-02 2013-06-26 普罗美加公司 腔肠素衍生物及其使用方法
US20130272966A1 (en) * 2012-04-12 2013-10-17 The Board Of Trustees Of The Leland Stanford Junior University Ret2ir conjugates, ret2ir conjugate systems and methods of use thereof
AU2013204332B2 (en) * 2012-04-16 2015-07-16 Commonwealth Scientific And Industrial Research Organisation Methods and systems for detecting an analyte or classifying a sample
US9624425B2 (en) * 2012-09-01 2017-04-18 Prolume, Ltd. Substituted benzo[f]imidazo[1,2-a]quinoxalines and imidazo[1,2-a]pyrazines
EP2900833B1 (en) 2012-09-26 2018-05-30 Promega Corporation Real-time monitoring
JP6654557B2 (ja) 2013-03-15 2020-02-26 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 構造的相補性による生物発光の活性化
US9952208B2 (en) 2013-07-18 2018-04-24 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Means and methods for bioluminescence resonance energy transfer (BRET) analysis in a biological sample
JP6588917B2 (ja) 2014-01-29 2019-10-09 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 生細胞への適用のためのプロ基質
EP2930497A1 (en) * 2014-04-07 2015-10-14 Institut Pasteur Enzyme-independent photon emission
SG11201609382WA (en) 2014-05-23 2016-12-29 Promega Corp Compositions and methods for stabilizing luminogenic substrates
JP6688499B2 (ja) * 2014-10-27 2020-04-28 国立大学法人 鹿児島大学 安定性が増加したウミシイタケ（Ｒｅｎｉｌｌａｒｅｎｉｆｏｒｍｉｓ）由来ルシフェラーゼ変異体
JP6704404B2 (ja) 2015-02-16 2020-06-03 マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー．ヴェー． ニコチンアミドアデニンジヌクレオチドを検出するためのセンサー、方法及びキット
US9908918B2 (en) 2015-06-30 2018-03-06 The Board Of Trustees Of The Leland Stanford Junior University Cyan-excitable orange-red fluorescent proteins and bioluminescent resonance energy transfer systems
EP3416968B1 (en) 2016-02-15 2022-07-27 Promega Corporation Coelenterazine analogues
EP3490991B1 (en) 2016-07-28 2021-01-06 Promega Corporation Coelenterazine analogues
JP6978492B2 (ja) 2016-09-09 2021-12-08 プロメガ コーポレイションPromega Corporation 二重保護されたプロセレンテラジン基質
US10280447B2 (en) 2016-11-01 2019-05-07 Promega Corporation Substituted imidazo[1,2-A]pyrazines tethered to energy acceptors
US10577370B2 (en) 2016-12-01 2020-03-03 Promega Corporation Cell impermeable coelenterazine analogues
US11959121B2 (en) * 2017-05-30 2024-04-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Sensors, methods and kits for detecting NADPH based on resonance energy transfer
PL3665481T3 (pl) * 2017-08-08 2024-02-05 PPB Technology Pty Ltd Czujniki węglowodanów
WO2019038375A1 (en) * 2017-08-25 2019-02-28 Technische Universiteit Eindhoven DETECTION DEVICE FOR THE BIOLUMINESCENT DETECTION OF BIOMARKERS IN A BIOLOGICAL FLUID SAMPLE USING LUMINESCENT DETECTION PROTEINS
JP7419260B2 (ja) 2018-05-01 2024-01-22 プロメガ コーポレイション ＮａｎｏＬｕｃ自殺基質としてのセレンテラジン化合物
KR20240060695A (ko) * 2018-06-29 2024-05-08 인터내셔날 페이퍼 컴퍼니 흡수성 물품용 화학발광 습윤 표시기
KR20210049854A (ko) 2018-08-23 2021-05-06 프로메가 코포레이션 코엘렌테라진 유사체

Also Published As

Publication number Publication date
JP7447101B2 (ja) 2024-03-11
BR112021006298A2 (pt) 2021-07-06
IL281844A (en) 2021-05-31
US20230092932A1 (en) 2023-03-23
EP3861128A2 (en) 2021-08-11
US11534504B2 (en) 2022-12-27
WO2020072775A2 (en) 2020-04-09
KR20210072040A (ko) 2021-06-16
AU2019355136A1 (en) 2021-04-29
CA3114424A1 (en) 2020-04-09
CN112996923A (zh) 2021-06-18
JP2022512611A (ja) 2022-02-07
US20200109146A1 (en) 2020-04-09
EP4015644A1 (en) 2022-06-22
WO2020072775A3 (en) 2020-07-23

Similar Documents

Publication Publication Date Title
IL277079A (en) Cartirin preparations and methods of use
IL284185A (en) Preparations for reducing DRG-specific transgene expression
IL272514A (en) Preparations and methods for genome modification
IL271232A (en) Compounds and methods for editing the genome
SG10201913040SA (en) Compositions and methods for stabilizing flaviviruses with improved formulations
IL283990A (en) Modified oxopyridine derivatives
IL276592A (en) History of Subtirum
IL286811A (en) Preparations and methods for stabilizing formulations containing proteins
IL287262A (en) Methods and preparations for transgene expression
IL276921A (en) Methods for changing body composition
IL279938A (en) History of spirochroman
EP3658590C0 (de) Photoinitiatoren für lichthärtende zusammensetzungen
IL271154A (en) Compounds and preparations for inducing cartilage formation
LT3796975T (lt) Sulfonilaminobenzamido dariniai
SG11202006144XA (en) Composition for protecting cornea
GB2569608B (en) Plasticiser composition
IL281844A (en) Compounds and methods for stabilizing coalintyrazine and its derivatives
IL282608A (en) Preparations and methods for NHEJ-mediated genome editing
GB201919180D0 (en) New composition of matter
KR102388028B9 (ko) 폴리펩타이드 전달용 조성물
HUE062256T2 (hu) Dihidrokromén-származékok
GB2566557B (en) Stabilising compositions
ZA202104923B (en) Soil stabilizing compositions
IL260405A (en) None-abusive derivatives of ritalin
GB201907363D0 (en) Stabilising composition